Increased expression of estrogen receptor-alpha (ER-α) is observed in 73–75% of diagnosed BC cases (Nadji et al., 2005; Rhodes et al., 2000) which leads to the disruption of various cellular processes (Seemayer et al., 2002). This evidence concerns the gene ESR1 and breast cancer.